Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, explain the benefits of testing for TRK fusion–positive tumors early for improved clinical outcomes.
Making a Difference with Early Identification and Treatment of Patients with NTRK Gene Fusions
Videos — July 19, 2021
Professor of Medicine
Chief
Division of Hematology/Oncology
UC San Diego
La Jolla, CA
Chief
Division of Hematology/Oncology
UC San Diego
La Jolla, CA
Associate Professor and Section Chief
Medical Oncology
Rush University Medical Center
Chicago, IL
Medical Oncology
Rush University Medical Center
Chicago, IL
Enterprise Medical Director of Research
Comprehensive Care and Research Center
Philadelphia, PA
Comprehensive Care and Research Center
Philadelphia, PA
